These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35116254)

  • 21. Good or not good: Role of miR-18a in cancer biology.
    Kolenda T; Guglas K; Kopczyńska M; Sobocińska J; Teresiak A; Bliźniak R; Lamperska K
    Rep Pract Oncol Radiother; 2020; 25(5):808-819. PubMed ID: 32884453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Classification of early and late stage liver hepatocellular carcinoma patients from their genomics and epigenomics profiles.
    Kaur H; Bhalla S; Raghava GPS
    PLoS One; 2019; 14(9):e0221476. PubMed ID: 31490960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of
    Zheng R; Zhu HL; Hu BR; Ruan XJ; Cai HJ
    World J Clin Cases; 2020 Jul; 8(14):2917-2929. PubMed ID: 32775374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An effective seven-CpG-based signature to predict survival in renal clear cell carcinoma by integrating DNA methylation and gene expression.
    Xu L; He J; Cai Q; Li M; Pu X; Guo Y
    Life Sci; 2020 Feb; 243():117289. PubMed ID: 31926254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma.
    Xing Q; Ji C; Zhu B; Cong R; Wang Y
    Cancer Med; 2020 Oct; 9(19):7034-7051. PubMed ID: 32780567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive analysis of the HOXA gene family identifies HOXA13 as a novel oncogenic gene in kidney renal clear cell carcinoma.
    Cui Y; Yan M; Zhang C; Xue J; Zhang Q; Ma S; Guan F; Cao W
    J Cancer Res Clin Oncol; 2020 Aug; 146(8):1993-2006. PubMed ID: 32444962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
    Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
    J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma.
    Zhou F; Shen D; Xiong Y; Cheng S; Xu H; Wang G; Qian K; Ju L; Zhang X
    Front Oncol; 2020; 10():570819. PubMed ID: 33628726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma.
    Song J; Peng J; Zhu C; Bai G; Liu Y; Zhu J; Liu J
    Cell Physiol Biochem; 2018; 48(6):2549-2562. PubMed ID: 30121668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma.
    Qi LW; Jia JH; Jiang CH; Hu JM
    Front Genet; 2020; 11():614566. PubMed ID: 33519919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pancancer analysis of oncogenic BARX2 identifying its prognostic value and immunological function in liver hepatocellular carcinoma.
    Yu S; Yang Y; Yang H; Peng L; Wu Z; Sun L; Wu Z; Yu X; Yin X
    Sci Rep; 2023 May; 13(1):7560. PubMed ID: 37161008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and Validation of Nine-RNA Binding Protein Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma.
    Zhong W; Huang C; Lin J; Zhu M; Zhong H; Chiang MH; Chiang HS; Hui MS; Lin Y; Huang J
    Front Genet; 2020; 11():568192. PubMed ID: 33133154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. APOA1 mRNA and protein in kidney renal clear cell carcinoma correlate with the disease outcome.
    Zeng W; Xiong G; Hua L; Hu Y; Guo X; Peng X
    Sci Rep; 2022 Jul; 12(1):12406. PubMed ID: 35858961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis.
    Wang R; Hu X; Liu X; Bai L; Gu J; Li Q
    PLoS One; 2021; 16(4):e0249881. PubMed ID: 33861762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating the Role of Neddylation Modifications in Kidney Renal Clear Cell Carcinoma: An Integrated Approach Using Bioinformatics, MLN4924 Dosing Experiments, and RNA Sequencing.
    Liu D; Wu G; Wang S; Zheng X; Che X
    Pharmaceuticals (Basel); 2024 May; 17(5):. PubMed ID: 38794205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and Validation of DEPDC1B as an Independent Early Diagnostic and Prognostic Biomarker in Liver Hepatocellular Carcinoma.
    Fan X; Wen J; Bao L; Gao F; Li Y; He D
    Front Genet; 2021; 12():681809. PubMed ID: 35095994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and clinical significance of NUF2 in kidney renal clear cell carcinoma.
    Shan L; Zhu XL; Zhang Y; Gu GJ; Cheng X
    Transl Androl Urol; 2021 Sep; 10(9):3628-3637. PubMed ID: 34733658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced GRAMD1C expression correlates to poor prognosis and immune infiltrates in kidney renal clear cell carcinoma.
    Hao H; Wang Z; Ren S; Shen H; Xian H; Ge W; Wang W
    PeerJ; 2019; 7():e8205. PubMed ID: 31875150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pan-cancer analysis identifies RNA helicase DDX1 as a prognostic marker.
    Gao B; Li X; Li S; Wang S; Wu J; Li J
    Phenomics; 2022 Feb; 2(1):33-49. PubMed ID: 36939765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a Pyroptosis-Related Prognostic Signature Combined With Experiments in Hepatocellular Carcinoma.
    Li H; Li T; Zhang X
    Front Mol Biosci; 2022; 9():822503. PubMed ID: 35309514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.